000 023630000a22003610004500
003 EG-GICUC
005 20250223032321.0
008 070317s2006 ua a f m 000 0 eng d
040 _aEG-GICUC
_beng
_cEG-GICUC
041 0 _aEng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.07.M.Sc.2006.Ma.R
100 0 _aManal Farouk Ahmed Abdelhafiz
245 1 0 _aRole and significance of DNA methylation in normal and abnormal hematopoiesis /
_cManal Farouk Ahmed Abdelhafiz ; Supervised Aisha Mostafa Abdelrahaman , Hoda Mohamed Abdelghani
246 1 5 _aدور و قيمة مثيلة الحمض النووى الديؤكسى ريبوزى فى تكوين الدم الطبيعى و الغير طبيعى
260 _aCairo :
_bManal Farouk Ahmed Abdelhafiz ,
_c2006
300 _a160P :
_bill ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Clinical and Chemical Pathology
520 _aData suggested that cancer appears to be a process that is fuelled both by genetic alterations and by epigenetic mechanisms Epigenetics refer to the study of changes in gene expression that can be mitotically inherited , but is not associated with the changes in the coding sequence of the affected genes The DNA methylation in the promoter regions is a powerful epigenetic mechanism for the suppression of gene activity Hypomethylation and hypermethylation are the two kinds of methylation defect that is observed in a wide variety of malignancies Hypomethylation is common in solid tumors such as metastatic hepatocellular cancer , in cervical cancer , prostate tumors , and also in hematological malignancies such as B - cell chronic lymphocytic leukemia A large number of genes involving fundamental cellular pathways may be affected by aberrant CpG island methylation in association with transcriptional silencing in virtually all tumor types
530 _aIssued also as CD
653 4 _aCpG islands
653 4 _aDNA methylation
653 4 _aEpigenetics in hematological malignancies
653 4 _aHypermethylation
653 4 _aHypomethylation
700 0 _aAisha Mostafa Abdelrahaman ,
_eSupervisor
700 0 _aHoda Mohamed Abdelghani ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aEnas
_ecataloger
905 _aMustafa
_eRevisor
942 _2ddc
_cTH
999 _c72622
_d72622